The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Brufen Retard 800mg prolonged release tablets



Viatris Healthcare LimitedPA23355/012/004

Main Information

Trade NameBrufen Retard 800mg prolonged release tablets
Active SubstancesIbuprofen
Dosage FormProlonged-release tablet
Licence HolderViatris Healthcare Limited
Licence NumberPA23355/012/004

Group Information

ATC CodeM01AE Propionic acid derivatives
M01AE01 ibuprofen

Status

License statusAuthorised
Licence Issued03/01/1990
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back